Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

Biohacking with Brittany

Day 3: How to Support Your Mitochondria and Feel the Difference with Timeline Nutrition

03 Dec 2022

Description

Welcome back to day 3 of 12 Days of Biohacking Gifts! Each day I will be interviewing a different health and wellness brand, hosting a giveaway for their products on my Instagram account, and sharing valuable information with you on how they're shaping the biohacking world. Day 3 is all about cellular nutrition. I have Ian Davison of Timeline Nutrition with me and we are featuring their Mitopure product. We talk about the factors that affect mitochondrial health, how mitophagy and autophagy work, how Urolithin A helps the process, and many more. Mitopure is the first nutrient clinically proven to trigger a crucial recycling process within our cells called mitophagy that prevents age-related cellular decline.  You can enter my giveaway now by going to my Instagram account @biohackingbrittany.   We talk about:  02:00 - The heart of the Timeline Nutrition products 03:00 - How Mitopure works in the body 04:05 - Signs that your mitochondria are functioning properly 05:30 - How autophagy works 06:30 - The benefits of Mitopure when taken daily 08:25 - Muscle function and aging 10:00 - Mitochondrial health for women 13:25 - Daily therapeutic level intake of MItopure  14:40 - Things that damage mitochondria 17:30 - The science behind eating pomegranate 19:10 - How modern-day living and nutrition affect the mitochondria   Resources:  Visit Timeline Nutrition and enter code BIOHACKINGBRITTANY. Let's Connect: Instagram Facebook Subscribe to my newsletter Shop my favorite health products Listen on Spotify, Apple Podcasts, Google Play

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.